On day 15 post cancer cell injection, 2 days after the 2nd administration of T cells, tumor size increased to above 75% from baseline for ~80% of mice in PBS-, CD8+ T-cell-, and CD27+Ly6C− γδ T-cell-treated groups. This evidence concerns the gene CD8A and neoplasm.